ArticleThe American journal of case reports2025
Severe Myoclonus Masking Thyroid Storm Following Etomidate Administration: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Oliceridine Pretreatment on Etomidate-Induced Myoclonus: A Proof-of-Concept Randomized Trial.Drug design, development and therapy · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Etomidate administration can induce thyroid storm-like symptoms, including tachycardia, palpitations, muscle weakness, tremors, hypermetabolism, and excessive sweating. The incidence of myoclonus after etomidate use is 50-80%, necessitating vigilant monitoring and management of patients. In contrast, thyroid storm is a critical complication of hyperthyroidism, involving a sudden surge in thyroid hormone levels, causing high fever, hypertension, severe arrhythmia, nervous system disturbances, and gastrointestinal symptoms, which require prompt medical attention to avert fatal outcomes. CASE REPORT A 37-year-old man underwent electronic bronchoscopy under general anesthesia due to pulmonary infection. Following induction with etomidate, he had severe myoclonus coupled with marked tachycardia, with a heart rate of 160-180 beats per minute. Despite intensifying the anesthesia, there was no notable amelioration in the myoclonus or tachycardia. Repeated administration of beta-blockers only managed to reduce the heart rate to approximately 150 beats per minute. The severe myoclonus and tachycardia persisted for about 20 minutes. Initially, we suspected that the severe myoclonus was a reaction to the etomidate injection. However, after conducting a more thorough history and laboratory tests, he was diagnosed with hyperthyroidism. On the first postoperative night, he had severe hypokalemia and bilateral lower-limb weakness, with muscle strength rated at 2 out of 5. Consequently, we concluded that this case involved severe myoclonus triggered by etomidate during general anesthesia, which obscured the symptoms of a thyroid storm. CONCLUSIONS This case provides a profound lesson and emphasizes the need for a comprehensive and vigilant approach in managing patients with hyperthyroidism undergoing surgical procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.